LifeMD Inc. (LFMD)
6.04
-0.02 (-0.33%)
At close: Apr 25, 2025, 3:59 PM
5.92
-2.07%
After-hours: Apr 25, 2025, 04:36 PM EDT
-0.33% (1D)
| Bid | 5.81 |
| Market Cap | 269.51M |
| Revenue (ttm) | 199.34M |
| Net Income (ttm) | -19.66M |
| EPS (ttm) | -0.53 |
| PE Ratio (ttm) | -11.41 |
| Forward PE | 32.33 |
| Analyst | Buy |
| Ask | 6.09 |
| Volume | 346,904 |
| Avg. Volume (20D) | 1,222,982 |
| Open | 6.00 |
| Previous Close | 6.06 |
| Day's Range | 5.91 - 6.05 |
| 52-Week Range | 3.99 - 12.88 |
| Beta | 2.23 |
About LFMD
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical ...
Industry Medical - Pharmaceuticals
Sector Healthcare
IPO Date Jan 29, 2008
Employees 304
Stock Exchange NASDAQ
Ticker Symbol LFMD
Website https://www.lifemd.com
Analyst Forecast
According to 6 analyst ratings, the average rating for LFMD stock is "Buy." The 12-month stock price forecast is $12, which is an increase of 98.51% from the latest price.
Stock ForecastsNext Earnings Release
LifeMD Inc. is scheduled to release its earnings on May 7, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+30.68%
LifeMD shares are trading higher after the company...
Unlock content with
Pro Subscription
1 month ago
-8.57%
LifeMD shares are trading higher after the company reported better-than-expected Q4 financial results and issued Q1 and FY25 revenue guidance above estimates.
